- How to prepare a manuscript?
- How to submit my new manuscript?
- The review process in IJO
- How to submit the revised manuscript?
- After acceptance
- Copyright and license agreement
1. How to prepare a manuscript
The manuscript should be submitted in the form of three separate files: Title Page/Main Manuscript/Cover Letter.
- Title page: Title page should contain the manuscript title, names of all authors and affiliations, and the name, address, email, and telephone number of the corresponding author who is responsible for communicating with the other authors about revisions and final approval of the proofs. Source(s) of support in the form of grants, equipment, drugs, or all of these and acknowledgments, if any, and the registration number for clinical trials and where it is registered (name of the registry and its URL) should also be included. Use doc/docx files. Do not zip the files.
- Main Manuscript File: The main text of the article, beginning from Abstract to References (not including tables and figures) should be in this file. The file must not contain any mention of the authors' names or the institution at which the study was done or acknowledgments. Manuscripts not in compliance with the Journal's blinding policy will be returned to the corresponding author for correction and resubmission. Use doc/docx files. Do not zip the files. The pages should be numbered consecutively, beginning with the first page of the main manuscript file.
- Cover Letter: The authors should certify all the authors have participated sufficiently in the conception and design of the work and neither the entire manuscript nor one with substantially similar content under their authorship has been published or is being considered for publication elsewhere. The cover letter should be signed by the corresponding author on behalf of all the authors. The cover letter sample link is available at: Cover Letter Sample
Guidelines for Original Articles
The abstract should concisely describe the purpose of the study, the hypothesis, methods, major findings, and conclusions. It should be organized into sections starting with the manuscript title, followed by Background and Aim, Methods, Results, and Conclusion. It should not exceed 250 words.
Three to six keywords must be listed below the abstract. These keywords should be selected based on the MESH (Medical Subject Heading) system. The authors’ information on the abstract page should not be included.
This section should include:
- Succinct statements of the issue in question
- The essence of existing knowledge and understanding pertinent to the issue (reference)
- The aims and objectives of the research must be mentioned clearly at the end of the introduction section
- All materials, procedures, and analytical techniques should be described. Use references to previously published works when needed.
- Identify names and sources of all commercial products, e.g., "The composite (Silar, 3M Co., St. Paul, MN, USA)...", "... CEM cement (BioniqueDent, Tehran, Iran)."
- Specify statistical significance test methods, including the software and version used for data analysis.
- Refer to appropriate tables and figures.
Tables should be numbered consecutively with Arabic numerals and should have an explanatory title. Each table should be typed on a separate page with regard to the proportion of the printed column/page and contain only horizontal lines.
All figures should be submitted electronically with the manuscript via Manuscript Central. Each figure should have a legend and all legends should be typed together on a separate sheet and numbered accordingly with Arabic numerals. Avoid 3-D bar charts.
- Refrain from subjective comments.
- Make no reference to previous literature. Only the findings of current research must be mentioned.
- Report statistical findings. P-values must be reported with the exact value, rounded to two decimal digits (avoid using p<0.05).
- Refer to appropriate tables and figures.
- Explain and interpret data. Do not report p-values in this section.
- State implications of the results related to composition.
- Indicate limitations of findings.
- Relate to other relevant research.
- Must NOT repeat information in the Results or Discussion section
- Must concisely state inference, significance, consequences as well as the clinical relevance of findings
All references should be cited within the text; otherwise, these references will be automatically removed. Authors are responsible for ensuring that the information in each reference is complete and accurate. The references should be numbered consecutively in the order in which they appear in the text (Vancouver system). All references must be numbered consecutively and citations of references in the text should be identified using numbers in parentheses. The DOI number should also be included for each reference.
Data Availability Statement
IJO encourages authors to make data and other materials related to methodology and results of submitted articles available to readers upon request from authors or as open access supplementary materials to the article. Therefore, manuscripts submitted to IJO should be accompanied by a data sharing statement. A data sharing statement describing whether and how the data will be made available is required for manuscripts reporting the results of clinical trials, in accordance with ICMJE recommendations. Consult ICMJE recommendations for more details. (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html#two).
Important notes for clinical trials
The manuscript structure is as mentioned for original articles for both the abstract and full-text body.
CONSORT statement: Authors of articles related to clinical trials must adhere to the Consolidated Standards of Reporting Trials statement (Consort Statement).
Registration of clinical trials: Effective March 1, 2013, as a condition for publication of any report of a clinical trial that began enrollment of participants on or after March 1, 2013, IJO requires that the clinical trial be registered publicly before any participants are enrolled in the study. Trials that began enrollment prior to March 1, 2013, also must be registered, but registration of such trials after enrollment of participants has begun is acceptable. The specific trial registration name and the registration number must be given. IJO editors will check manuscripts on submission to determine if the study requires registration. Clinical trials need not be registered on any specific website; such as IRCT.ir or any international registries, which can be found on the International Committee of Medical Journal Editors website (http://www.icmje.org/about-icmje/faqs/clinical-trials-registration). If such a manuscript is accepted for publication, the trial registration name and registration number will be published at the end of the article's abstract.
Guidelines for Systematic Reviews and Meta-Analyses
Systematic reviews and meta-analyses submitted to the IJO are screened for compliance with the PRISMA (preferred reporting items for
systematic reviews and meta-analyses) guidelines. Therefore, systematic reviews and meta-analyses should be prepared according to the
PRISMA guidelines. Please download the PRISMA checklist and flow diagram and submit it with your article.
Summaries for systematic reviews and meta-analyses should be in a structured format and follow the PRISMA guidelines. When applicable the
summary should contain the following subtitles: Background, Objectives, Search methods, Selection criteria, Data collection and analysis,
Results, and Conclusions.
Guidelines for Review Articles
Review articles are accepted based on invitation-only by the Editor. Review articles for the IJO should include:
- Main Manuscript including tables and figures
Guidelines for Short Communications
Short communications should have no more than 1000 words (excluding abstract, tables, figures, legends, and references), and a maximum total of four figures and/or tables combined and no more than 25 references.
Guidelines for Case Series/Report
This type of publication is best suited to describe significant improvements in clinical practice such as the introduction of new technology or
practical approaches to recognized clinical challenges. They should conform to the highest scientific and clinical practice standards.
2. How to submit my new manuscript?
All new manuscripts must be submitted via IJO online submission website. Authors should click the “Submit Manuscript” menu on the left of the homepage and follow the step-by-step process to create an account and submit a manuscript. If you have forgotten your login password, you can use the password recovery system on the login page. If you experience any problems, please contact the editorial office by e-mail at firstname.lastname@example.org.
3. The review process in IJO
All Original Articles, Review Articles, Case reports/Series and Short Communications, and Technical Notes submitted to IJO go under the initial screening process by the editorial office before inviting reviewers. The topic of the manuscript will be checked to adapt to the scope of IJO. Incomplete submissions without the required documents will be sent back to the author’s submission dashboard in his/her profile, which can be found under the “Submissions Sent Back to Author” link. The initial evaluation will be done several days after submission.
Once the initial screening process is completed, the article will be assessed using the double-blind peer-review procedure. The average time for the first decision is a maximum of three months.
4. How to revise my manuscript?
In the case of receiving reviewers’ comments, the author(s) may need to revise and resubmit the manuscript. Note that receiving the comments does not guarantee the acceptance of your article. Any changes in the manuscript must be highlighted in yellow. A separate docx file must be prepared to contain the author(s) responses to the reviewers’ comments and each question or comment must be followed by its relevant response. This file should be named, "Response to the Reviewers" and must be submitted with the revised manuscript. If this file is not included with the revised manuscript, the manuscript will be resent to the corresponding author.
After preparing the revised manuscript, log in to your profile using your username and password. On the submission page, all necessary files must be uploaded in separate doc/docx files.
4.1. Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the first submission. Any addition, deletion, or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in the author list and (b) written confirmation (e-mail or letter) from all the authors that they agree with the addition, removal, or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. If the manuscript has already been accepted or published in an online issue, requests will not be accepted.
5. After Acceptance
Once the manuscript is accepted for publication in the IJO, an acceptance declaration will be sent to the corresponding author through the system and e-mail. After the preparation of the manuscript, one set of page proofs (as a PDF file) will be sent through the system to the corresponding author. The author can use the PDF annotations facility, for which you will need to download Adobe Reader version 9 (or higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany the proofs (given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Queries) and return them to IJO through the system as a supplementary file. List your corrections quoting line number. Use this proof only for checking the typesetting, editing, completeness, and correctness of the text, tables, and figures. Significant changes to the article are not permitted at this stage. It is important to ensure that all corrections are sent back to us in one communication: check carefully before replying, as the inclusion of any subsequent corrections cannot be guaranteed. The author is responsible for responding to ALL queries sent to them by the Editorial office. If the queries are not replied to, the manuscript will be temporarily removed from the publishing process and postponed. If, after one month, the Journal does not recieve any file in reponse to the queries, IJO has the right to completely reject the manuscript.
6. Copyright and License agreement
- Copyright of the open-access article in the IJO is retained by the author(s).
- Authors grant IJO and Sinaweb the license to publish the article and identify themselves as the original publisher.
- Authors also grant any third party the right to use the article for any non-commercial use, as long as its integrity is maintained and its original authors, citation details, and publisher are identified.
- The Creative Commons Attribution-NonCommercial License 4.0 formalizes these and other terms and conditions of publishing articles.
6.2. License Agreement
In submitting an article to the IJO I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- The article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal, and does not infringe any existing copyright or any other third-party rights.
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to Sinaweb are not in breach of any other obligation.
- The article contains nothing that is unlawful, libelous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy.
- I/we have taken due care to ensure the integrity of the article. To my/our and currently accepted scientific knowledge, all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness, or damage to the user.
- I and all co-authors agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial License 4.0.
- I and all co-authors, agree that, if the article is editorially accepted for publication in the Iranian Journal of Orthodontics, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated.
6.3. Article Processing Charge
As the Iranian Association of Orthodontists supports all of the publishing costs of the IJO, the article processing charge and any other publication fees in the Journal are free for authors. Moreover, IJO is published as an open-access electronic journal, so there is no subscription fee for audiences. Authors under the CC BY-NC license may share and distribute their articles on non-commercial websites and repositories immediately upon publication.
7.1. Manuscript originality and author identification and roles
The cover letter should provide the originality of the submitted manuscript declaration and whether it was not been published or is under consideration for publication or review elsewhere. Each author’s name, degrees, professional title, work affiliations, complete address, telephone and fax numbers, and valid email address, in the order that will appear in the article in the case of acceptance for publication. In the end, the funding institute (including the grant number) or any other financial support for the current manuscript must be provided. All authors must provide a brief statement of responsibility detailing what they contributed to the manuscript following their names. The cover letter sample link is available at: Cover Letter Sample
7.2. Publication ethics
The ethical policy of the Journal is based on the Committee on Publication Ethics (COPE) guidelines and complies with the International Committee of Journal Editorial Board codes of conduct. Readers, authors, reviewers, and editors should follow these ethical policies once working with the Journal. The ethical policy of the Journal is liable to determine what research papers or articles submitted to the Journal should be published in the concerned issue. The publishing decision is based on the suggestion of the Journal's reviewers and editorial board members. The ethical policy states that the Editor-in-Chief may confer with other editors or reviewers in making the decision. The reviewers are required to evaluate research papers based on the submitted content in a confidential manner. The reviewers also suggest to the authors how to improve the quality of the research paper by their reviewing comments.
Authors should ensure that their submitted research work is original and has not been published or has been submitted and is being considered for publishing elsewhere in any language. Applicable copyright laws and conventions should be followed by the authors. Any kind of plagiarism constitutes unethical publishing behavior and is unacceptable. For more information on the Journal's guidelines regarding publication ethics please visit https://www.ijorth.com/journal/process?ethics. .
7.3. Human and animal rights
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans, http://www.wma.net/en/30publications/10policies/b3/index.html. Uniform requirements for manuscripts submitted to Biomedical journals can be found at http://www.icmje.org. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
IJO will not include papers based on work that involves unnecessary pain, distress, suffering, or lasting harm in animal subjects. Manuscripts describing research involving live animals must include appropriate details of animals used, housing and feeding, experimental design, experimental procedures, ethical considerations, licenses, and approvals under which the work was carried out in Materials and Methods section.